{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:39:38Z","timestamp":1792636778367,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002774"],"award-info":[{"award-number":["82002774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002774"],"award-info":[{"award-number":["82002774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05193-0","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T07:21:56Z","timestamp":1785050516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A circRNA platform for safe partial reprogramming and rejuvenation of mesenchymal stem cells without pluripotent conversion"],"prefix":"10.1186","volume":"17","author":[{"given":"Yumei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"issue":"8","key":"5193_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1021\/acsptsci.4c00284","volume":"7","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang M, Wang H. Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies. ACS Pharmacol Translational Sci. 2024;7(8):20.","journal-title":"ACS Pharmacol Translational Sci"},{"issue":"5","key":"5193_CR2","doi-asserted-by":"publisher","first-page":"e2213","DOI":"10.1371\/journal.pone.0002213","volume":"3","author":"W Wagner","year":"2008","unstructured":"Wagner W, et al. Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process. PLoS ONE. 2008;3(5):e2213.","journal-title":"PLoS ONE"},{"issue":"1","key":"5193_CR3","first-page":"91","volume":"4","author":"E Suzanne","year":"2014","unstructured":"Suzanne E, Berry. Concise Review: Mesoangioblast and Mesenchymal Stem Cell Therapy for Muscular Dystrophy: Progress, Challenges, and Future Directions. Stem Cells Translational Med. 2014;4(1):91\u20138.","journal-title":"Stem Cells Translational Med"},{"issue":"7","key":"5193_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/cells12070998","volume":"12","author":"M Cheng","year":"2023","unstructured":"Cheng M, et al. Rejuvenation of mesenchymal stem cells to ameliorate skeletal aging. Cells. 2023;12(7):998.","journal-title":"Cells"},{"issue":"1","key":"5193_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41598-025-30633-x","volume":"16","author":"E Pekker","year":"2025","unstructured":"Pekker E, et al. Comprehensive bulk and single-cell RNA sequencing uncovers senescence-associated biomarkers in therapeutic mesenchymal stem cells. Sci Rep. 2025;16(1):999.","journal-title":"Sci Rep"},{"issue":"5","key":"5193_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.14336\/AD.2023.0208","volume":"14","author":"X Jiang","year":"2023","unstructured":"Jiang X, et al. Mesenchymal stem cell senescence during aging: from mechanisms to rejuvenation strategies. Aging disease. 2023;14(5):1651.","journal-title":"Aging disease"},{"issue":"12","key":"5193_CR7","doi-asserted-by":"publisher","first-page":"114349","DOI":"10.4252\/wjsc.v17.i12.114349","volume":"17","author":"NF Mayeen","year":"2025","unstructured":"Mayeen NF, et al. Hurdles to overcome for mesenchymal stem cell translation from bench to bedside. World J Stem Cells. 2025;17(12):114349.","journal-title":"World J Stem Cells"},{"issue":"7942","key":"5193_CR8","first-page":"169","volume":"613","author":"V Moiseeva","year":"2023","unstructured":"Moiseeva V, et al. Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration. Nat Aging. 2023;613(7942):169\u201378.","journal-title":"Nat Aging"},{"issue":"3","key":"5193_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s43587-022-00183-2","volume":"2","author":"KC Browder","year":"2022","unstructured":"Browder KC, et al. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice. Nat Aging. 2022;2(3):243\u201353.","journal-title":"Nat Aging"},{"issue":"3","key":"5193_CR10","doi-asserted-by":"publisher","first-page":"e13578","DOI":"10.1111\/acel.13578","volume":"21","author":"D Chondronasiou","year":"2022","unstructured":"Chondronasiou D, et al. Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming. Aging Cell. 2022;21(3):e13578.","journal-title":"Aging Cell"},{"issue":"1","key":"5193_CR11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41467-020-15174-3","volume":"11","author":"TJ Sarkar","year":"2020","unstructured":"Sarkar TJ, et al. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat Commun. 2020;11(1):1545.","journal-title":"Nat Commun"},{"issue":"4","key":"5193_CR12","doi-asserted-by":"publisher","first-page":"2200208","DOI":"10.1002\/bies.202200208","volume":"45","author":"D Puri","year":"2023","unstructured":"Puri D, Wagner W. Epigenetic rejuvenation by partial reprogramming. BioEssays. 2023;45(4):2200208.","journal-title":"BioEssays"},{"key":"5193_CR13","doi-asserted-by":"crossref","unstructured":"Y\u00fccel AD, Gladyshev VN. The long and winding road of reprogramming-induced rejuvenation. Nature communications, 2024. 15(1): p. 1941.","DOI":"10.1038\/s41467-024-46020-5"},{"issue":"1","key":"5193_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/cell.2023.0072","volume":"26","author":"CC Macip","year":"2024","unstructured":"Macip CC, et al. Gene therapy-mediated partial reprogramming extends lifespan and reverses age-related changes in aged mice. Cell Reprogramming. 2024;26(1):24\u201332.","journal-title":"Cell Reprogramming"},{"issue":"8","key":"5193_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/vaccines13080821","volume":"13","author":"YY Zhao","year":"2025","unstructured":"Zhao YY, et al. Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics. Vaccines. 2025;13(8):821.","journal-title":"Vaccines"},{"key":"5193_CR16","doi-asserted-by":"crossref","unstructured":"Niazi SK. mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework. RSC Pharm, 2026.","DOI":"10.1039\/D5PM00159E"},{"issue":"11","key":"5193_CR17","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.3390\/ijms26115138","volume":"26","author":"E Broset","year":"2025","unstructured":"Broset E, et al. A complete approach for circRNA therapeutics from purification to lyophilized delivery using novel ionizable lipids. Int J Mol Sci. 2025;26(11):5138.","journal-title":"Int J Mol Sci"},{"key":"5193_CR18","doi-asserted-by":"crossref","unstructured":"Swingle KL et al. Circular RNA lipid nanoparticle vaccine against SARS-CoV-2. Proc Natl Acad Sci USA, 2025. 122(38).","DOI":"10.1073\/pnas.2505718122"},{"issue":"10","key":"5193_CR19","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1093\/nar\/gkz199","volume":"47","author":"A Cherubini","year":"2019","unstructured":"Cherubini A, et al. FOXP1 circular RNA sustains mesenchymal stem cell identity via microRNA inhibition. Nucleic Acids Res. 2019;47(10):5325\u201340.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5193_CR20","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"WR Alexander","year":"2018","unstructured":"Alexander WR, Kowalski PS, Anderson DG. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 2018;9(1):2629.","journal-title":"Nat Commun"},{"issue":"7978","key":"5193_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","volume":"621","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature. 2023;621(7978):396\u2013403.","journal-title":"Nature"},{"key":"5193_CR22","unstructured":"Xu C et al. Improving the circularization efficiency, stability and translatability of circular RNA by circDesign. Europepmc, 2023. bioRxiv."},{"issue":"7","key":"5193_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/chemosensors12070120","volume":"12","author":"F Cheng","year":"2024","unstructured":"Cheng F, et al. Study on the characterization and degradation pattern of circular RNA vaccines using an HPLC method. Chemosensors. 2024;12(7):120.","journal-title":"Chemosensors"},{"issue":"8","key":"5193_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.31083\/j.fbl2708239","volume":"27","author":"H Shi","year":"2022","unstructured":"Shi H, et al. Universal markers for hiPSCs residue detection. Front Bioscience-Landmark. 2022;27(8):239.","journal-title":"Front Bioscience-Landmark"},{"key":"5193_CR25","doi-asserted-by":"publisher","first-page":"1627149","DOI":"10.3389\/fcell.2025.1627149","volume":"13","author":"S Dhaiban","year":"2025","unstructured":"Dhaiban S, Chandran S, Sajini A. Clinical translation of human iPSC technologies: advances, safety concerns, and future directions. Front Cell Dev Biology. 2025;13:1627149.","journal-title":"Front Cell Dev Biology"},{"issue":"5","key":"5193_CR26","doi-asserted-by":"publisher","first-page":"e37342","DOI":"10.1371\/journal.pone.0037342","volume":"7","author":"T Kuroda","year":"2012","unstructured":"Kuroda T, et al. Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PLoS ONE. 2012;7(5):e37342.","journal-title":"PLoS ONE"},{"issue":"4","key":"5193_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, et al. Cellular senescence: defining a path forward. Cell. 2019;179(4):813\u201327.","journal-title":"Cell"},{"issue":"1","key":"5193_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.it.2010.10.005","volume":"32","author":"W Ouyang","year":"2011","unstructured":"Ouyang W, Li MO. Foxo: in command of T-lymphocyte homeostasis and tolerance. Trends Immunol. 2011;32(1):26\u201333.","journal-title":"Trends Immunol"},{"issue":"7","key":"5193_CR29","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","volume":"167","author":"A Ocampo","year":"2016","unstructured":"Ocampo A, et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell. 2016;167(7):1719\u201333.","journal-title":"Cell"},{"key":"5193_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","volume":"348","author":"X Liu","year":"2022","unstructured":"Liu X, et al. Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. J Controlled Release. 2022;348:84\u201394.","journal-title":"J Controlled Release"},{"issue":"10","key":"5193_CR31","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","volume":"185","author":"L Qu","year":"2022","unstructured":"Qu L, et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell. 2022;185(10):1728\u201344. e16.","journal-title":"Cell"},{"issue":"1","key":"5193_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41580-023-00649-0","volume":"25","author":"MJ Rodriguez-Colman","year":"2024","unstructured":"Rodriguez-Colman MJ, Dansen TB, Burgering BMT. FOXO transcription factors as mediators of stress adaptation. Nat Rev Mol Cell Biol. 2024;25(1):46\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"5193_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm3507","volume":"14","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom A, Burgering BM. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol. 2013;14(2):83\u201397.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"5193_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.stem.2007.07.017","volume":"1","author":"Z Tothova","year":"2007","unstructured":"Tothova Z, Gilliland DG. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell. 2007;1(2):140\u201352.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"5193_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nbt0602-592","volume":"20","author":"JL Simonsen","year":"2002","unstructured":"Simonsen JL, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002;20(6):592\u20136.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"5193_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.stemcr.2014.07.003","volume":"3","author":"J Frobel","year":"2014","unstructured":"Frobel J, et al. Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Rep. 2014;3(3):414\u201322.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"5193_CR37","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"G Jacques","year":"2018","unstructured":"Jacques G, Luc S. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. 2018;22(6):824\u201333.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"5193_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3 K, et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23(2):165\u201375.","journal-title":"Immunity"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05193-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:12:04Z","timestamp":1792635124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05193-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5193"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05193-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used a commercially available cell line obtained from ATCC who had initial ethical approval for collecting human cells and signed informed consent from the donor under a Material Transfer Agreement that restricting the usage of the cells to research only (\n                      \n                      ), and thus did not require additional ethics approval.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"376"}}